BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11891102)

  • 1. Tubulo-interstitial nephritis caused by sodium valproate.
    Yoshikawa H; Watanabe T; Abe T
    Brain Dev; 2002 Mar; 24(2):102-5. PubMed ID: 11891102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Biopsy Findings in a Patient With Valproic Acid-Associated Fanconi Syndrome.
    Singer P; Sethna CB; Castellanos-Reyes L; Yaskiv O; Bijol V
    Pediatr Dev Pathol; 2019; 22(4):370-374. PubMed ID: 30565480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi syndrome caused by valproic acid.
    Endo A; Fujita Y; Fuchigami T; Takahashi S; Mugishima H
    Pediatr Neurol; 2010 Apr; 42(4):287-90. PubMed ID: 20304335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy.
    Fukuda Y; Watanabe H; Ohtomo Y; Yabuta K
    Nephron; 1996; 72(2):328-9. PubMed ID: 8684554
    [No Abstract]   [Full Text] [Related]  

  • 7. [A severe case of interstitial nephritis caused by sodium valproate].
    Martuseviciene G; Kamper AL; Horn T
    Ugeskr Laeger; 2006 Oct; 168(43):3729-30. PubMed ID: 17069740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of chronic tubulo-interstitial nephritis].
    Watanabe H; Fukuda Y; Ohtomo Y; Yabuta K; Hirano K; Tomino Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1101-5. PubMed ID: 1289610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fever of unknown origin as the initial manifestation of valproate-induced Fanconi syndrome.
    Nozaki F; Kumada T; Kusunoki T; Fujii T; Murayama K; Ohtake A
    Pediatr Neurol; 2014 Dec; 51(6):846-9. PubMed ID: 25439492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.
    Min HK; Kim EO; Lee SJ; Chang YK; Suh KS; Yang CW; Kim SY; Hwang HS
    BMC Nephrol; 2013 Jan; 14():13. PubMed ID: 23320835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 12. Ranitidine-associated interstitial nephritis and Fanconi syndrome.
    Neelakantappa K; Gallo GR; Lowenstein J
    Am J Kidney Dis; 1993 Aug; 22(2):333-6. PubMed ID: 8352262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Nakayasu K; Nagayama Y
    Eur J Pediatr; 2005 Mar; 164(3):186-7. PubMed ID: 15717181
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome.
    Torimoto K; Okada Y; Arao T; Mori H; Tanaka Y
    Endocr J; 2012; 59(12):1051-6. PubMed ID: 22814143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate-induced Fanconi type proximal renal tubular acidosis.
    Knights M; Thekkekkara T; Morris A; Finlay E
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26823359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-valproate-induced interstitial nephritis.
    Lin CY; Chiang H
    Nephron; 1988; 48(1):43-6. PubMed ID: 3124010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

  • 19. [Three cases of Fanconi syndrome associated with valproate sodium treatment].
    Inoue T; Tanaka Y; Otani R; Itabashi H; Murakami N; Nagai T; Sakuta R
    No To Hattatsu; 2011 May; 43(3):233-7. PubMed ID: 21638910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sodium valproate on the renal function of children with epilepsy.
    Knights MJ; Finlay E
    Pediatr Nephrol; 2014 Jul; 29(7):1131-8. PubMed ID: 23720013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.